Zhong Guo Jing Ji Wang·2025-10-23 00:33Group 1: Core Insights - The technology sector has shown remarkable performance in the third quarter, with the Yongying Technology Smart Selection fund achieving a 194% increase, leading to a significant growth in fund size from 1.166 billion to 11.521 billion yuan [1][2] - The top holdings of the Yongying Technology Smart Selection fund include high-performing stocks in the optical module sector, contributing significantly to the fund's net value [2] - The innovative drug sector has also performed well, with funds like Changcheng Pharmaceutical Industry Selection seeing over 100% growth, despite a recent pullback [4][5] Group 2: Fund Performance and Holdings - Yongying Technology Smart Selection's net value increased by 99.74% in the third quarter, with major holdings including Xinyisheng, Zhongji Xuchuang, and Tianfu Communication [2] - Changcheng Pharmaceutical Industry Selection's top holdings include major biotech firms, with a fund size increase from 1.132 billion to 1.790 billion yuan [4][5] - The fund manager of Changcheng Pharmaceutical expressed optimism about the value of innovative drug stocks, indicating a shift towards a focus on clinical data and overseas licensing [5][7] Group 3: Market Outlook - The fund managers believe that both technology and pharmaceutical sectors still have potential for growth, although careful stock selection is necessary [7] - The global cloud computing industry is expected to continue growing, with AI models seeing increased value and investment [3][8] - The technology and PCB industries are anticipated to experience significant developments by 2027, with new technologies expected to emerge [8]